Literature DB >> 18759083

Neonatal thrombocytopenia associated with maternal pregnancy induced hypertension.

Y Ramesh Bhat1, Carol S Cherian.   

Abstract

OBJECTIVE: To evaluate the prevalence of thrombocytopenia in neonates born to mothers with pregnancy induced hypertension (PIH) and identify the associated material and neonatal characteristics.
METHODS: In the current, prospective study, platelet counts were assessed serially. Maternal and neonatal characteristic were recorded in pre-designed proforma. Primary outcome measures were thrombocytopenia defined as platelet count of <150,000/mm(3) and severe thrombocytopenia if counts were <30,000/mm(3) or <50,000/mm(3) with bleeding.
RESULTS: Of 97 neonates born to PIH mothers 35 (36.1%) had thrombocytopenia. In 20 (20.6%) thrombocytopenia was severe. Higher percentage of thrombocytopenia was associated with male gender (47.7%), low birth weight (71.4%) and prematurity (67.4%). Severe thrombocytopenia was significantly associated with low birth weight (OR: 4.58; 95% CI: 0.98-21.3; p<0.03) and prematurity (OR: 2.52; 95% CI: 0.87-7.24; p<0.05). Material parity, onset of PIH, and medications did not seem to be associated significantly.
CONCLUSION: Premature and low birth weight neonates born to mothers with pregnancy induced hypertension would require scrutiny for thrombocytopenia during early neonatal period.

Entities:  

Mesh:

Year:  2008        PMID: 18759083     DOI: 10.1007/s12098-008-0110-x

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN: 0019-5456            Impact factor:   1.967


  8 in total

Review 1.  Evaluation and treatment of thrombocytopenia in the neonatal intensive care unit.

Authors:  N A Murray
Journal:  Acta Paediatr Suppl       Date:  2002

2.  Thrombocytopenia at delivery: a prospective survey of 6715 deliveries.

Authors:  R F Burrows; J G Kelton
Journal:  Am J Obstet Gynecol       Date:  1990-03       Impact factor: 8.661

3.  The thrombopoietin level in the cord blood in premature infants born to mothers with pregnancy-induced hypertension.

Authors:  Po-Nien Tsao; Ru-Jeng Teng; Hung-Chieh Chou; Kuo-Inn Tsou
Journal:  Biol Neonate       Date:  2002

Review 4.  Neonatal thrombocytopenia: causes and management.

Authors:  I Roberts; N A Murray
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2003-09       Impact factor: 5.747

5.  Neutropenia in high-risk neonates.

Authors:  W D Engle; C R Rosenfeld
Journal:  J Pediatr       Date:  1984-12       Impact factor: 4.406

6.  How often does maternal preeclampsia-eclampsia incite thrombocytopenia in the fetus?

Authors:  J A Pritchard; F G Cunningham; S A Pritchard; R A Mason
Journal:  Obstet Gynecol       Date:  1987-03       Impact factor: 7.661

7.  Neonatal manifestations of severe maternal hypertension occurring before the thirty-sixth week of pregnancy.

Authors:  J E Brazy; J K Grimm; V A Little
Journal:  J Pediatr       Date:  1982-02       Impact factor: 4.406

8.  Neonatal thrombocytopenia in the hypertensive disorders of pregnancy.

Authors:  R F Burrows; M Andrew
Journal:  Obstet Gynecol       Date:  1990-08       Impact factor: 7.661

  8 in total
  2 in total

1.  Neonatal Thrombocytopenia as a Consequence of Maternal Preeclampsia.

Authors:  Ram R Kalagiri; Saiara Choudhury; Timothy Carder; Vinayak Govande; Madhava R Beeram; M Nasir Uddin
Journal:  AJP Rep       Date:  2015-10-28

2.  Effect of Maternal Preeclampsia on Hematological Profile of Newborns in Qatar.

Authors:  Mohammad A A Bayoumi; Abir A H Ali; Sara G Hamad; Alaa A M Ali; Einas E Elmalik; Mohamed M I R Elkalaf; Bassem A A Moustafa; Deena A D A Shaltout; Prem Chandra; Lisa J Langtree; Noimot O Olayiwola
Journal:  Biomed Res Int       Date:  2020-03-12       Impact factor: 3.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.